vs
CAPITAL CITY BANK GROUP INC（CCBG）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
CAPITAL CITY BANK GROUP INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$63.5M vs $35.5M），CAPITAL CITY BANK GROUP INC净利率更高（21.6% vs -304.2%，领先325.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 6.0%），CAPITAL CITY BANK GROUP INC自由现金流更多（$80.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 6.0%）
德克萨斯首都银行是一家总部位于得克萨斯州达拉斯的银行，在得克萨斯州所有主要城市均设有网点，其母公司控股公司为得克萨斯首都银行控股集团，同时该机构还运营着纯线上银行部门Bask Bank。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CCBG vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $35.5M |
| 净利润 | $13.7M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 29.3% | -304.8% |
| 净利率 | 21.6% | -304.2% |
| 营收同比 | 6.0% | 681.7% |
| 净利润同比 | 4.7% | 39.6% |
| 每股收益（稀释后） | $0.80 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $63.5M | $35.5M | ||
| Q3 25 | $65.9M | $5.2M | ||
| Q2 25 | $63.2M | $19.2M | ||
| Q1 25 | $61.5M | $14.7M | ||
| Q4 24 | $59.9M | $4.5M | ||
| Q3 24 | $59.7M | $26.1M | ||
| Q2 24 | $58.9M | $14.4M | ||
| Q1 24 | $56.5M | $13.8M |
| Q4 25 | $13.7M | $-108.1M | ||
| Q3 25 | $15.9M | $-162.3M | ||
| Q2 25 | $15.0M | $-171.9M | ||
| Q1 25 | $16.9M | $-202.5M | ||
| Q4 24 | $13.1M | $-178.9M | ||
| Q3 24 | $13.1M | $-95.8M | ||
| Q2 24 | $14.2M | $-97.5M | ||
| Q1 24 | $12.6M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 29.3% | -304.8% | ||
| Q3 25 | 32.0% | -3327.6% | ||
| Q2 25 | 31.7% | -916.8% | ||
| Q1 25 | 35.8% | -1297.9% | ||
| Q4 24 | 29.0% | -4042.4% | ||
| Q3 24 | 26.1% | -377.1% | ||
| Q2 24 | 29.3% | -697.4% | ||
| Q1 24 | 27.2% | -698.4% |
| Q4 25 | 21.6% | -304.2% | ||
| Q3 25 | 24.2% | -3135.3% | ||
| Q2 25 | 23.8% | -894.2% | ||
| Q1 25 | 27.4% | -1373.3% | ||
| Q4 24 | 21.9% | -3935.5% | ||
| Q3 24 | 22.0% | -367.5% | ||
| Q2 24 | 24.0% | -676.6% | ||
| Q1 24 | 22.2% | -662.4% |
| Q4 25 | $0.80 | $-0.17 | ||
| Q3 25 | $0.93 | $-0.36 | ||
| Q2 25 | $0.88 | $-0.41 | ||
| Q1 25 | $0.99 | $-0.50 | ||
| Q4 24 | $0.78 | $-0.56 | ||
| Q3 24 | $0.77 | $-0.34 | ||
| Q2 24 | $0.83 | $-0.40 | ||
| Q1 24 | $0.74 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $552.9M | $1.1B |
| 总资产 | $4.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $552.9M | $1.1B | ||
| Q3 25 | $540.6M | $1.0B | ||
| Q2 25 | $526.4M | $919.1M | ||
| Q1 25 | $512.6M | $933.9M | ||
| Q4 24 | $495.3M | $1.0B | ||
| Q3 24 | $476.5M | $524.6M | ||
| Q2 24 | $461.0M | $584.4M | ||
| Q1 24 | $448.3M | $401.2M |
| Q4 25 | $4.4B | $1.5B | ||
| Q3 25 | $4.3B | $1.4B | ||
| Q2 25 | $4.4B | $1.3B | ||
| Q1 25 | $4.5B | $1.3B | ||
| Q4 24 | $4.3B | $1.4B | ||
| Q3 24 | $4.2B | $726.5M | ||
| Q2 24 | $4.2B | $775.9M | ||
| Q1 24 | $4.3B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $80.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 126.1% | -133.1% |
| 资本支出强度资本支出/营收 | 12.0% | 3.5% |
| 现金转化率经营现金流/净利润 | 6.39× | — |
| 过去12个月自由现金流最近4个季度 | $150.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $87.6M | $-46.1M | ||
| Q3 25 | $21.6M | $-117.4M | ||
| Q2 25 | $32.6M | $-76.4M | ||
| Q1 25 | $21.9M | $-132.0M | ||
| Q4 24 | $63.6M | $-115.4M | ||
| Q3 24 | $12.8M | $-59.2M | ||
| Q2 24 | $24.9M | $-82.2M | ||
| Q1 24 | $14.6M | $-102.3M |
| Q4 25 | $80.0M | $-47.3M | ||
| Q3 25 | $19.8M | $-117.6M | ||
| Q2 25 | $30.8M | $-79.6M | ||
| Q1 25 | $19.5M | $-133.8M | ||
| Q4 24 | $54.9M | $-116.7M | ||
| Q3 24 | $10.5M | $-63.8M | ||
| Q2 24 | $23.0M | $-83.4M | ||
| Q1 24 | $12.4M | $-109.0M |
| Q4 25 | 126.1% | -133.1% | ||
| Q3 25 | 30.1% | -2272.5% | ||
| Q2 25 | 48.7% | -413.9% | ||
| Q1 25 | 31.7% | -907.4% | ||
| Q4 24 | 91.7% | -2567.7% | ||
| Q3 24 | 17.6% | -244.6% | ||
| Q2 24 | 39.0% | -578.5% | ||
| Q1 24 | 22.0% | -789.9% |
| Q4 25 | 12.0% | 3.5% | ||
| Q3 25 | 2.6% | 4.7% | ||
| Q2 25 | 2.9% | 16.4% | ||
| Q1 25 | 3.9% | 12.4% | ||
| Q4 24 | 14.5% | 28.6% | ||
| Q3 24 | 3.8% | 17.5% | ||
| Q2 24 | 3.3% | 8.2% | ||
| Q1 24 | 4.0% | 48.2% |
| Q4 25 | 6.39× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 2.17× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 4.86× | — | ||
| Q3 24 | 0.97× | — | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
